4//SEC Filing
Wade M. Andrew 4
Accession 0001209191-19-062055
CIK 0001323885other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 7:49 AM ET
Size
8.9 KB
Accession
0001209191-19-062055
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wade M. Andrew
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2019-12-26$11.20/sh+1,000$11,200→ 145,715 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-26−1,000→ 0 totalExercise: $11.20From: 2012-02-09Exp: 2021-02-09→ Common Stock (1,000 underlying) - Sale
Common Stock
2019-12-26$32.00/sh−1,000$32,000→ 144,715 total
Footnotes (3)
- [F1]These shares were exercised pursuant to a 10b5-1 trading plan.
- [F2]These shares were sold pursuant to a 10b5-1 trading plan.
- [F3]This option was granted on February 9, 2011. The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001560591
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 7:49 AM ET
- Size
- 8.9 KB